Novavax (NVAX)
(Delayed Data from NSDQ)
$4.93 USD
+0.22 (4.67%)
Updated May 3, 2024 04:00 PM ET
After-Market: $4.90 -0.03 (-0.61%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum D VGM
Brokerage Reports
Novavax, Inc. [NVAX]
Reports for Purchase
Showing records 1 - 20 ( 294 total )
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
FY23 Results: 4Q and Recent Results Make for a More Agile Organization
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for NVAX 12223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for NVAX 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for NVAX 111123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
3Q23 Results Mark a Major Milestone; Reiterate Buy Rating and $35 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Model Changes; Reiterate Buy and $35 Price Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for NVAX 11123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Novavax, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for NVAX 102123
Provider: Stock Traders Daily
Analyst: Research Department